Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Total Non-Current Liabilities (2016 - 2025)

Fresenius Medical Care AG has reported Total Non-Current Liabilities over the past 17 years, most recently at $12.2 billion for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $12.2 billion for Q4 2025, down 6.0% from a year ago — trailing twelve months through Dec 2025 was $12.2 billion (down 6.0% YoY), and the annual figure for FY2025 was $12.2 billion, down 6.0%.
  • Total Non-Current Liabilities for Q4 2025 was $12.2 billion at Fresenius Medical Care AG, down from $13.0 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for FMCQF hit a ceiling of $15.0 billion in Q4 2021 and a floor of $12.2 billion in Q4 2025.
  • Median Total Non-Current Liabilities over the past 5 years was $14.0 billion (2023), compared with a mean of $13.7 billion.
  • Biggest five-year swings in Total Non-Current Liabilities: decreased 0.99% in 2023 and later dropped 7.21% in 2024.
  • Fresenius Medical Care AG's Total Non-Current Liabilities stood at $15.0 billion in 2021, then decreased by 6.01% to $14.1 billion in 2022, then fell by 0.99% to $14.0 billion in 2023, then dropped by 7.21% to $13.0 billion in 2024, then decreased by 6.0% to $12.2 billion in 2025.
  • The last three reported values for Total Non-Current Liabilities were $12.2 billion (Q4 2025), $13.0 billion (Q4 2024), and $14.0 billion (Q4 2023) per Business Quant data.